Biopharma's stock market winners of 2022 revealed

Pipeline performers including Lilly, Daiichi and Sarepta topped the stock market gainers last year, as the Covid trade was thoroughly unwound.

GSK 2022: A newly focused biopharma company - PharmaLive

The sky is the limit: the trillion-dollar biopharma company? - IQVIA

Quarterly shareprice performance

Evaluate Search

I-Mab Provides Business and Corporate Updates and Reports

Evaluate Search

S&P 500 closes lower, notches 5-day losing streak ahead of key

Stock market correction sends biopharma back to the start of 2021

Evaluate Search

Connect Biopharma Stock Plummets

Evaluate Search

The most productive biopharma workforces of 2021

Fate Therapeutics

Pharma 2023 Half-year review reveals winners and losers

The Inflation Reduction Act's impact on pharma